Bixiye
P56-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective December 6, 2021
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2211 - 2220 ee natiijooyinka 3289
Bixiye
P55-21 Early Intensive Developmental and Behavioral Intervention (EIDBI) Service Authorization and Claims Submission for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P59-21 New: eviCore Home Health Care (HHC) Supplementary Guidelines for Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P57-21 2022 Renewal Changes Summary for Primary Care Clinic Providers
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
QP75-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Weight Loss Agents
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP73-21 Medical Drug Update – RSV Health Alert and Palivizumab (Synagis)
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP74-21 Chantix Recall and Shortage
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP72-21 Commercial and MHCP Pharmacy Benefit Exclusion for Saphnelo
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP71-21 Provider Sharing of Protected Health Information (PHI) with Care Coordinators for Minnesota Health Care Program Members
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP70-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective November 1, 2021
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 08, 2021